That is true , all the research Pfizer is doing and spending money on is extremely helpful to CYDY , we only going after diseases their research showing improvement , starting with GvHD. This is why I have this feeling that we will in some form end up with them at the end , they really know value of CCR5 inhibitors the most imo ...
I had the same hope but learned that a mab does not pass the blood brain barrier. Maraviroc is a small molecule so it's a different story. So I have little hope we will be able to treat stroke recovery, Alzheimer or Parkinson disease.